Post-therapeutical changes in the brain: Novel trends in imaging and their infuence on external beam radiotherapy

Neoplasma

Volumn 56, Issue 2, 2009, Pages 156-162

  Chorvath, M ^a   Boljesikova, E ^a   Pruzincova, L ^b   Procka, V ^c   Rychly, B ^b   Novotny, M ^d   Kalina, P ^c   Belan, V ^b   Makaiova, I ^c   Steno, J ^c  

^a St Elisabeth Cancer Institute   (Slovakia)

^b Derer 's University Hospital Slovakia   (Slovakia)

^c Faculty of Natural Sciences   (Slovakia)

^d NONE

Author keywords

3D conformal radiotherapy (3D CRT); MRI; PET; Radiation necrosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; ARTICLE; BRAIN BIOPSY; BRAIN INJURY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; EXTERNAL BEAM RADIOTHERAPY; GLIOMA; HUMAN; HUMAN TISSUE; LATE DELAYED THERAPY INDUCED INJURY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; RADIATION INJURY; RADIATION NECROSIS; RISK FACTOR; SENSITIVITY AND SPECIFICITY; BRAIN; BRAIN TUMOR; MIDDLE AGED; PATHOLOGY; RADIATION EXPOSURE;

ADULT; BRAIN; BRAIN NEOPLASMS; FLUORODEOXYGLUCOSE F18; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY;

EID: 65649142609     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2009_02_156     Document Type: Article

References (28)

1. Stupp R, HEGI ME, BENT MJ et al. Changing paradigms-an update on the multidisciplinary management of malignant glioma The Oncologist 2006; 11: 165-180. doi:10.1634/theoncologist.11-2-165 PMid:16476837
2. GRIER JT, BATCHELOR T. Low-grade gliomas in adults The Oncologist 2006; 11: 681-693. doi:10.1634/theoncologist. 11-6-681 PMid:16794247
3. KARIM ABM, AFRA D, CORNU P et al. Randomized trial on efficacy of radiotherapy for cerebral low-grade gioma in the adult: EORTC of cancer study 22845 with the research council study BRO4: an interim analysis. Int. J. Radiation Oncology Biol Phys.2002; 52: 316-324. doi:10.1016/s0360-3016(01)02692- X
4. Schiff D, BROWN PD, GIANNINI C. Outcome in adult low-grade glioma: The impact of prognostic factors and treatment Neurology 2007; 69: 1366-1373. doi:10.1212/01. wnl.0000277271.47601.a1 PMid:17893297
5. RUBEN JD, DALLY M, BAILEY M et al. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy Int. J. Radiation Oncology Biol. Phys.2006; 65: 499-508. doi:10.1016/j. ijrobp.2005.12.002
6. Tsien Ch, Gomez-Hassan D, CHENEVERT TL et al. Predicting outcome of patients with high grade glioma after radiotherapy using quantitative analysis of T1-weighted magnetic resonance imaging. Int. J. Radiation Oncology Biol Phys.2007; 67: pp 1476-1483. doi:10.1016/j.ijrobp.2006.11.020
7. JOHANNESEN TB, LIEN HH, HOLE KH et al. Radiological and clinical assessment of long-term brain tumour survivors after radiotherapy. Radiotherapy and Oncology 2003; 69: 169-176. doi:10.1016/s0167-8140(03)00192-0 PMid:14643954
8. Perry A, SCHMIDT RE. Cancer therapy-associated Cns neuropathology: an update and review of the literature acta Neuropathol 2006; 111: 197-212. doi:10.1007/s00401-005-0023-y PMid:16463065
9. KUMAR AJ, NORMAN EL, FULLER GN et al. Malignant Gliomas: MR Imaging Spectrum of Radiation Therapy- and Chemotherapy-induced Necrosis of the Brain after Treatment. Radiology 2000; 217: 377.
10. Armstrong Cl, HUNTER JV, HACKEY D et al. MRI changes due to early-delayed conformal radiotherapy and postsurgical effects in patients with brain tumours. Int. J. Radiation Oncology Biol Phys.2005; 63: pp 56-63. doi:10.1016/j. ijrobp.2004.12.073
11. Sugahara T, Korogi Y, Tomiguchi S et al. Posttherapeutic Intraaxial Brain Tumour: The Value of Perfusion-sensitive Contrast-enhanced MR Imaging for Differentiating Tumour recurrence from nonneoplastic Contrast-enhancing tissue. AJNR Am. J. Neuroradiol., May 2000; 21: 901-909. (Pubitemid 30262837)
12. HEIN PA, ESKEY CJ, DUNN JF et al. Diffusion-Weighted Imaging in the Follow-up of Treated High-Grade Gliomas: Tumour Recurrence versus Radiation Injury AJNR Am. J. Neuroradiol., Feb 2004; 25: 201-209.
13. Lev MH, Ozsunar Y, Henson JW et al. Glial tumour Grading and Outcome Prediction Using Dynamic Spin Echo MR Susceptibility Mapping Compared with Conventional Contrast-Enhanced Mr: Confounding Effect on Elevated rCBV of Oligodendrogiomas Am. J. Neuroradiol., Feb 2004; 25: 214-221.
14. Asao Ch, Korogi Y, Kitajima M et al. Diffusion-weighted imaging of radiation-induced brain injury for differentiation from tumour recurrence. AJNR Am. J. Neuroradiol., Jun 2005; 26: 1455-1460. (Pubitemid 43733446)
15. SCHLEMMER HP, BACHERT P, HERFAHRT KK et al. Proton MR Spectroscopic Evaluation of Suspicious Brain Lesions After Stereotactic Radiotherapy AJNR Am. J. Neuroradiol., Aug 2001; 22: 1316-1324.
16. Kimura T, Sako K, Tohyama Y et al. Diagnosis and treatment of progressive space-occupying radiation necrosis following stereotactic radiosurgery for brain metastasis: value of proton magnetic resonance spectroscopy. Acta Neurochirurgica, 2003 Jul; Vol.145 (7), pp. 557-564 doi:10.1007/s00701-003-0051- 0 PMid:12910398
17. Wurm G, Parsaei B, Silye R et al. distinct supratentorial lesions mimicking cerebral gliomas. Acta Neurochirurgica 2004 Jan; Vol.146 (1), pp. 19-26; doi:10.1007/s00701-003-0151-x PMid:14740261
18. LICHY MP, PLATHOW CH, SCHULZ-ERTNER D et al. Follow up gliomas after radiotherapy: 1H MR spectroscopic imaging for increasing diagnostic accuracy. Neuroradiology 2005; 47: 826-834. doi:10.1007/s00234-005-1434-0 PMid:16142479
19. ZENG QS, LI CF, LIU H et al. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. Int. J. Radiation Oncology Biol Phys.2007; 68: pp 151-158. doi:10.1016/j.ijrobp.2006.12.001
20. LANGLEBEN DD, SEGALL GM. PET in differentiation of recurrent brain tumour from radiation injury. J Nucl Med 2000; 41: 1861-1867.
21. Kahn D, FOLLETT KA, BUSHNELL DL et al. Diagnosis of recurrent brain tumour: value of 201t1 SPECT vs. 18F-Fluorodeoxyglucose PET. AJR Am J Roentgenol 1994; 163: 1459-1465.
22. OLIVERO WC, DULEBOHN SC, LISTER JR. The use of PET in evaluating patients with primary brain tumours: is it useful? J Neurol Neurosurg Psychiatry 1995; 58: 250-252. doi:10.1136/jnnp.58.2.250
23. CHUNG JK, KIM YK, KIN S, LEE YJ, PAEK S et al. Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo-orisometabolic on 18F-FDG PET. Eur. J Nucl. Med 2002; 29: 176-182. doi:10.1007/s00259-001-0690-4 PMid:11926379 (Pubitemid 34143449)
24. Van Laere K, Ceyssens S, Van Calenbergh F et al. Direct comparison of 18F-FDG and 11C-methionine PET in suspected recurrence of glioma: sensitivity, inter-observer variability and prognostic value. Eur J Nucl Med Mol Imaging 2005; 32: 39-51. doi:10.1007/s00259-004-1564-3 PMid:15309329 (Pubitemid 40142777)
25. Chen W. Clinical applications of PET in brain tumours. J Nucl Med 2007; 48: 1468-1481. doi:10.2967/jnumed.106.037689 PMid:17704239 (Pubitemid 47397397)
26. SCHIEPERS CH, CHEN W, DAHLBOM M, CLOUGHESY T, HOH CK, HUANG SCh. 18F-fluorothymidine kinetics of malignant brain tumours. Eur J Nucl Med Mol Imaging 2007; 34: 1003-1011.
27. Spaeth N, Wyss MT, Weber B, Schiedegger S, LUTZ A et all. Uptake of 18F-Fluorocholine, 18F-Fluoroethyl-L-Tyrosine, and 18F-FDG in acute cerebral radiation injury in the rat: implications for separation of radiation necrosis from tumour recurrence. J Nucl Med 2004; 45: 1931-1938. (Pubitemid 47618453)
28. Hermanto U, FRIJA EK, LII MJ et al. Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotheraphy for high grade gliomas: does IMRT increase the integral dose to normal brain? Int. J. Radiation Oncology Biol Phys.2007; 67: 1135-1144. doi:10.1016/j.ijrobp.2006.10. 032